We studied the effects of new nootropic and neuroprotective drug Noopept (N-phenylacetyl-L-prolylglycine ethyl ester) in various dosage regimens on the dynamics of glycemia, body weight, and pain sensitivity in rats receiving diabetogenic toxin streptozotocin. In experimental diabetic rats, Noopept alleviated glycemia and weight loss and normalized enhanced pain sensitivity. The normalizing effect of Noopept was most pronounced when it was administered as a preventive agent prior to injection of the toxin. Both preventive and therapeutic administration of Noopept (delayed injections included) significantly weakened the examined metabolic effects of diabetogenic toxin. Possible mechanisms of the antidiabetic action of Noopept are analyzed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
L. P. Kovalenko, M. G. Miramedova, S. V. Alekseeva, et al., Eksper. Klin. Farmakol., 65, No. 2, 53-55 (2002).
A. V. Lysenko, N. I. Uskova, R. U. Ostrovskaya, et al., Eksper. Klin. Farmakol., 60, No. 5, 15-18 (1997).
A. M. Mendzheritskii, A. V. Lysenko, S. V. Dem’yanenko, et al., Neirokhimia, 20, No. 4, 281-286 (2003).
R. U. Ostrovskaya, U. V. Vakhitova, M. Kh. Salimgareeva, et al., Eksper. Klin. Farmakol., 73, No. 12, 2-6 (2010).
A. A. Spasov, V. A. Kosolapov, and N. I. Cheplyaeva, Eksper. Klin. Farmakol., 74, No. 11, 14-16 (2011).
T. N. Fedorova, K. S. Us, R. U. Ostrovskaya, Neirokhimia, 24, No. 1, 69-73 (2007).
S. Golbidi, M. Badran, I. Laher, Front. Pharmacol., 2, 69 (2011).
T. A. Gudasheva, T. A. Voronina, R. U. Ostrovskaya, et al., Eur. J. Med. Chem., 31, No. 2, 151-157 (1996).
B. Ludwig, C. G. Ziegler, A. V. Schally, et al., Proc. Natl. Acad. Sci. USA, 107, No. 28, 12,623-12,628 (2010).
M. T. Lortz, M. Tiedge, T. Nachtwey, et al., Diabetes, 49, No. 7, 1123-1130 (2000).
R. U. Ostrovskaya, T. A. Gudasheva, S. S. Trofimov, et al., Biological Basis of Individual Sensitivity to Psychotropic Drugs, Eds. G. Gaviraghi, V. Longo, S. Seredenin, Edinburg, 79-91 (1994).
A. Pelsman, C. Hoyo-Vadillo, T.A. Gudasheva et al., Int. J. Dev. Neurosci, 21, No. 3, 117-124 (2003).
G. Pittenger and A. Vinnik, Exp. Diabesity Res., 4, No. 4, 271-285 (2003).
S. B. Seredenin, T. A. Voronina, T. A. Gudasheva, et al., Biologically Active N-Acylprolyldipeptides Having Antiamnestic, Antihypoxic, and Anorexigenic Effects, Patent US No. 5.439.930, Aug. 8, 1995.
T. Skudelski, Physiol. Res., 50, No. 6, 537-546 (2001).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 154, No. 9, pp. 317-321, September, 2012
Rights and permissions
About this article
Cite this article
Ostrovskaya, R.U., Ozerova, I.V., Gudascheva, T.A. et al. Efficiency of Noopept in Streptozotocin-Induced Diabetes in Rats. Bull Exp Biol Med 154, 334–338 (2013). https://doi.org/10.1007/s10517-013-1944-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-013-1944-4